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Abatract
OBJECTIVE: To explore the effect of Linguizhugan
decoction on hyperlipidemia rats with caloric re-
striction.
METHODS: The hyperlipidemia model of rat was in-
duced by high fat diet for 8 weeks. After the model
was established, 26 rats were randomly divided in-
to 4 groups: the control group (n=6), the model
group (n=6), the intermittent fasting (IF) group (n=
8), and the IF and herbal medicine (IFH) group (n=
6). IF group was applied intermittent fasting every
other day. The IFH group was given Linguizhugan
decoction every day and intermittent fasting every
other day. Blood samples were taken at the end of
16 weeks, and serum ghrelin and lipid was tested.
RESULTS: Serum ghrelin in the IF group significant-
ly increased (P<0.01). Serum ghrelin in IFH group
was lower than the IF group (P<0.05), but higher
than the model group (P<0.01).
CONCLUSION: Linguizhugan decoction may play a
part in regulation of energy and appetite in hyper-
lipidemia rats with IF.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Lingguizhugan decoction is a classical formula from Jin
Gui Yao Lue.1 It is widely used to treat phlegm and flu-
id syndrome. In the previous studies, we have used this
decoction combined with fasting therapy to treat
obese, hyperlipidemia, insulin resistance, and 2 type di-
abetes, and found that patients were less hunger than
those only with fasting therapy, and more likely to
complete fasting therapy.2 Therefore, we predicted that
Lingguizhugan decoction might have some effect on
the regulation of energy and appetite during fasting
therapy. Ghrelin is regarded as an index of food intake
and energy homeostasis. In this research, serum ghrelin
was investigated in the hyperlipidemia rats with inter-
mittent fasting (IF) and Chinese herbal medicine.
METHODS
Animal and diet
A total of 26 Wistar rats [Number of animal license
SOXK (Guangdong) 2008-0002], weighing (200±10) g
obtained from Experimental animal centre of SUN
YAT-SEN University were fed in a specific pathogen
free cage in the Experimental Animal Center of North
Campus of Sun Yat-sen University. After receiving
adaptive feeding for 7 days, rats were divided into two
groups randomly: 6 rats (control group) fed with nor-
mal diet and 20 with high fat diet (HFD) (basic diet
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78.3% , lard 10% , egg yolk power 10% , cholesterol
1%, bile salts 0.5%, propylthiouracil 0.2%, whole calo-
rie was 17.4 kcal/g, provided by Experimental Animal
Center of Guangdong Province).
After HFD for 8 weeks, blood lipid was tested. Blood
lipid of HFD rats was significantly higher than that of
control group, suggesting that the model was regarded
to be successful. Then, hyperlipidemia rats were divid-
ed into three groups: 1) model group: maintained on
HFD. 2) IF group: fasting every other day. On fasting
day, rats were fed no food but water from 8 am to 8
am the next day. On non-fasting day, rats were fed
HFD and water freely. 3) IF with herbal medicine
group: given Lingguizhugan decoction everyday by ga-
vage, and intermittent fasting the same as IF group. Af-
ter 8 weeks, rats were sacrficed under anesthesia, and
fasting plasma were collected. All animal studies were
approved by the Medical Ethics Committee of the first
affiliated hospital of Sun Yan-sun University.
Drugs and reagent
Lingguizhugan decoction, made from granule, was con-
sisted of Fuling (Poria), Guizhi (Ramulus Cinnamomi),
Baizhu (Rhizoma Atractylodis Macrocephalae), Zhigan-
cao (Radix Glycyrrhizae, honey-fried) at the ratio of 12∶
9∶6∶6. The powder was diluted by normal saline to
make a new concentration of 0.344 g/mL. The dosage
of administration via stomach was 3.44 g/kg-1·d-1.
Ghrelin reagent was purchased from Uscn Life Science,
Inc. (Wuhan, China). Serum lipid was tested by the
laboratory department of the first affiliated hospital of
Sun Yat-sun university.
Statistical analysis
Statistical analyses were performed using SPSS 17.0
(SPSS Inc, Chicago, IL, USA). All the normal variables
are expressed as mean±standard deviation (mean±SD).
The comparison of two groups was analyzed by inde-
pendent samples t test. P<0.05 was regarded as statisti-
cally significant.
RESULTS
Comparison of serum lipid
As showed in the Table 1, levels of total cholesterol
(TC), total glycerin (TG), low-density lipoprotein cho-
lesterol (LDL-C) in the model group were all higher
than the control group (all P<0.01). In the IF group,
TC level was lower (P<0.01)and high-density lipopro-
teincholesterol (HDL-C) was higher ((P<0.01) as com-
pared with the model group. Similarly, TC level in the
IFH group was lower (P<0.01) and HDL-C was high-
er (P<0.01) than the model group. However, levels of
TC, TG, HDL-C, LDL-C showed no statistical differ-
ence between the IF group and the IFH group (P>
0.05).
Comparison of serum ghrelin
The ghrelin level in the model group [(314 ± 95) pg/
mL] was lower than the control group [(503±129) pg/
mL] (P=0.016). Compared with the model group, it
was higher in the IF group [(683 ± 123) pg/mL] (P=
0.0001). Compared with the IF group, ghrelin level in
the IFH group [(490 ± 118) pg/mL] was lower (P=
0.011), but it was still higher than the model group (P=
0.011).
DISSCUSION
Metabolic syndrome includes hyperinsulinemia, insu-
lin resistance, visceral obesity, and dyslipidemia. Calor-
ic restriction (CR) is important in the guideline of met-
abolic syndrome, obesity and type 2 diabetes. CR by
30% over a period of 3 months could improve insulin
clearance, and play an important role in the normaliza-
tion of insulin and lipid metabolism in liver.3
Fasting as one type of CR has been applied in treating
metabolic syndrome, obesity and type-2 diabetes in the
past three years by us.2 During 7 days fasting, patients
ate no food but water and juice and stopped taking any
hypoglycemic drugs. Some patients might quit the fast-
ing therapy because of great hunger, dizziness and fa-
tigue. When we added Lingguizhugan decoction into
fasting therapy, patients' suffering lightened, and felt
easier to complete the treatment. Therefore, we guess
Lingguizhugan may play a role in regulation of appe-
tite and energy metabolism.
From Table 1, it is showed that serum lipid in the IF
and IFH group had no statistical difference. Compared
with the model group, TC levels in two groups were
Table 1 comparison of serum lipid in four groups (mmol/L, xˉ ± s )
Group
Control
Model
IF
IFH
n
6
6
8
6
TC
1.70±0.27
3.56±0.75a
2.01±0.31b
2.21±0.33bc
TG
0.65±0.29
1.29±0.19a
1.01±0.25
1.16±0.42c
HDL-C
0.53±0.10
0.77±0.37
0.94±0.10b
1.01±0.12bc
LDL-C
0.23±0.09
0.53±0.21a
0.51±0.09
0.51±0.13c
Notes: control: rats fed with normal diet; model: rats fed with high fat diet; IF: model rats treated with intermittent fasting; IFH: model
rats treated with Lingguizhugan decoction and intermittent fasting. TC: total cholesterol; TG: total glycerin; HDL-C: high-density
lipoproteincholesterol; LDL-C: low-density lipoprotein cholesterol. Compared with control group, aP<0.01; compared with model group.
bP<0.01; compared with IF group, cP>0.05.
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lower than the model group, while the HDL-C levels
were all higher than the model group, indicating that
IF could reduce TC and increase HDL-C. Here the
herbal medicine showed no effect on the serum lipid.
However, the serum ghrelin level was lower in the IFH
group than the IF group.
Ghrelin was discovered in 1999 by Kojima and col-
leagues from extracts of rat gastric tissue.4 Stomach is a
major source of circulating ghrelin (65%-90% ),5 and
the second is small intestine. Brain, pituitary, pancreas,
kidney, lung, placenta, testis, and ovary also express de-
tectable amounts of ghrelin.6Ghrelin is the first and on-
ly gut peptide proven to have orexigenic properties. En-
dogenous ghrelin levels are closely related to meal pat-
terns, rising before meals and falling within 1 h after
meal.7 Both central and peripheral administration of
ghrelin results in increased food intake.8 Ghrelin in-
creases in the plasma during diet-induced weight loss
in obese human.9 Suggesting that ghrelin may contrib-
ute to the sustained appetite associated with CR. In
our study, we applied IF to rats, ghrelin was significant-
ly higher than model group. When we add Linggui-
zhugan to IF rats, serum ghrelin level dropped com-
pared to IF groups (P<0.01), suggesting that the decoc-
tion regulates appetite of IF rats, and may played a role
in appetite regulation of patients so that they felt less
hunger and able to complete the treatment easily.
Lingguizhugan decoction is from Jin Gui Yao Lue.1 It
has the effect of warming Yang for resolving fluid reten-
tion and invigorating the spleen for eliminating damp-
ness. In long-term CR, body gets energy mainly from
fat, muscle and gluconeogenesis. Due to the decompo-
sion of fat and muscle by fasting, patients felt great diz-
zy, tired and susceptible to cold, and this symptom is
corresponding to Yang-deficiency syndrome. With the
use of decoction, energy homeostasis maybe improved
in hyperlipidemia patients with fasting, suggesting that
Lingguizhugan decoction isn't placebo but plays a part
in fasting therapy. However, the mechanism of Linggui-
zhugan decoction on appetite and energy homeostasis
is still unknown in the fasting patients. We propose
that it may lie in the regulation of feeding center dur-
ing fasting, so further research on this field will be
needed in the future.
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